What Researchers Did
Researchers performed angiography on 51 patients with various cancers to observe if angiotensin II-induced high blood pressure could increase blood flow to tumors.
What They Found
They observed that increased tumor blood flow under angiotensin II-induced high blood pressure resulted from tumor blood vessels not responding to angiotensin II. Angiographic findings showed increased tumor vascularity in 40 (78.4%) of the 51 patients. The study suggested that this increased tumor blood flow, by potentially raising tumor oxygen levels, could be useful in hyperbaric oxygenation radiotherapy.
What This Means for Canadian Patients
This early research explored a method to potentially enhance the effectiveness of radiation therapy for cancer by increasing blood flow and oxygen to tumors. While not a direct HBOT study, it suggested a theoretical pathway where hyperbaric oxygen therapy combined with this approach might improve treatment outcomes for cancer patients. However, this was a preliminary observation and not a clinical trial of HBOT itself.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This 1986 observational study only suggested a theoretical possibility for hyperbaric oxygenation radiotherapy based on an assumption of increased tumor oxygen, without directly testing HBOT or its clinical outcomes.